We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

58 hedge funds and large institutions have $23.7M invested in IVERIC bio, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $22.6M → $23.7M (+$1.13M)

8% less funds holding

Funds holding: 6358 (-5)

15% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 20

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
58
Holders Change
-5
Holders Change %
-7.94%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
6
Increased
17
Reduced
20
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$85
APA
52
American Portfolios Advisors
New York
$71
SM
53
Sabby Management
Florida
-$2.44M -2,037,460 Closed
MERSOM
54
Municipal Employees' Retirement System of Michigan
Michigan
-$460K -383,660 Closed
BFM
55
Boothbay Fund Management
New York
-$112K -93,533 Closed
Rockefeller Capital Management
56
Rockefeller Capital Management
New York
-$44K -36,540 Closed
Jane Street
57
Jane Street
New York
-$23K -19,069 Closed
Squarepoint
58
Squarepoint
New York
-$18K -14,888 Closed
Goldman Sachs
59
Goldman Sachs
New York
-$16K -13,541 Closed
Group One Trading
60
Group One Trading
Illinois
-$4K -3,372 Closed
Macquarie Group
61
Macquarie Group
Australia
-$1K -1,147 Closed
AG
62
Advisor Group
Arizona
-$6 -4 -15%

ISEE Hedge Fund Activity: Q1 2019 in Review

58 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2019, worth a combined $23.7M — up 5% from $22.6M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ISEE and 6 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 17 added.

The largest buyer was Tamarack Advisers, adding an estimated $2.8M. The largest seller was D.E. Shaw & Co, cutting an estimated $2.57M.

  • 58 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2019, down from 63 in Q4 2018.
  • Funds reported $23.7M of IVERIC bio, Inc. Common Stock stock for Q1 2019, up 5% quarter-over-quarter.
  • 6 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2019 and 11 closed out, a net change of -5 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q1 2019 was Tamarack Advisers, an estimated $2.8M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q1 2019 was D.E. Shaw & Co, an estimated $2.57M sold.

Based on aggregated 13F filings for Q1 2019.